The Life Sciences and Debt Finance teams advised Collegium Pharmaceutical (Nasdaq: COLL) in connection with a financing from Pharmakon where the company obtained $646 million in senior secured debt financing to support the acquisition of Ironshore Therapeutics. Pharmakon Advisors provided the debt financing which replaced its existing $650 million loan to Collegium.
Collegium Pharmaceutical, based in Stoughton, Mass., is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions.
The Goodwin team was led by Jennifer Porter, Dylan Brown, Lucas Burbank, Avia Cohen, Kenneth Armstrong and Kate Riddle, with invaluable assistance from Michele Eason-Priest.
For more information, please read the press release.